Luye Pharma Buys Majority Stake In Beijing Jialin For $599 Million

August 29, 2014 -- Luye Pharma of China will pay $599 million to acquire a 58% stake in Beijing Jialin Pharmaceutical Co., a company that makes drug products for cardiovascular diseases and cancer. In 2013, Jialin produced $185 million of revenue. Last month, Luye staged a $764 million IPO in Hong Kong, and the shares have risen 41% since the IPO. According to Luye, the deal will add to its portfolio of cardiovascular drugs and broaden its sales network.

Help employers find you! Check out all the jobs and post your resume.